Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study

BACKGROUND: Dexamethasone decreases mortality in patients with severe coronavirus disease 2019 (COVID-19) and has become the standard of care during the second wave of pandemic. Dexamethasone is an immunosuppressive treatment potentially increasing the risk of secondary hospital acquired infections...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Intensive Care
Prif Awduron: Gragueb-Chatti, Ines, Lopez, Alexandre, Hamidi, Dany, Guervilly, Christophe, Loundou, Anderson, Daviet, Florence, Cassir, Nadim, Papazian, Laurent, Forel, Jean-Marie, Leone, Marc, Dellamonica, Jean, Hraiech, Sami
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer International Publishing 2021
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8165680/
https://ncbi.nlm.nih.gov/pubmed/34057642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13613-021-00876-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg